Guangzhou Sianxin Biotechnology Co.
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $47M
Investors
- 2
About Guangzhou Sianxin Biotechnology Co.
, Ltd. is a medical health company that focuses on research and development of innovative vaccine vector technologies and the development of novel vaccines. The company's founder, Dr. Biao He, is a tenured and Fred Davison Professor at the University of Georgia. In August 2021, this company completed a GMP-compliant viral vaccine development and pilot production site. In June 2021, the company received clinical trial approval from the US FDA for the development of a new coronavirus vaccine and initiated Phase I clinical trials in August. The company self-developed products include PIV5 virus vector platform and bioreactor serum-free continuous perfusion culture technology platform for virus vaccine preparation. PIV5 virus vector platform has vaccines for viruses such as COVID-19, influenza virus, respiratory syncytial virus, middle east respiratory syndrome virus and mycobacterium tuberculosis. The bioreactor serum-free continuous perfusion culture technology platform for virus vaccine preparation has cell scale up and freeze storage technology, large scale cell seed preparation technology, bioreactor continuous perfusion serum-free large scale culture Vero cell technology, virus vaccine purification technology, virus vaccine heat stabilised formulation and lyophilised formulation technology.
Who invested in Guangzhou Sianxin Biotechnology Co.
2 investors across 1 round
See all investors in Guangzhou Sianxin Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 26, 2022
Amount
$47M
Investors
Questions about Guangzhou Sianxin Biotechnology Co.
Who invested in Guangzhou Sianxin Biotechnology Co.?
Guangzhou Sianxin Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guangzhou Sianxin Biotechnology Co. raised?
Guangzhou Sianxin Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Guangzhou Sianxin Biotechnology Co. last raise money?
Guangzhou Sianxin Biotechnology Co.'s most recent round on record is a Series A, in Jan 2022.
What does Guangzhou Sianxin Biotechnology Co. do?
Guangzhou Sianxin Biotechnology Co. is a biotechnology company.
Where is Guangzhou Sianxin Biotechnology Co. headquartered?
Guangzhou Sianxin Biotechnology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Guangzhou Sianxin Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Guangzhou Sianxin Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Guangzhou Sianxin Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.